Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation

[1]  J. Douketis.  Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management. , 2010, Current pharmaceutical design.

[2]  A. Spyropoulos.  Bridging therapy and oral anticoagulation: current and future prospects , 2010, Current opinion in hematology.

[3]  J. Douketis,et al.  Risk of stroke after surgery in patients with and without chronic atrial fibrillation , 2010, Journal of thrombosis and haemostasis : JTH.

[4]  M. Feuring,et al.  Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity , 2010, Thrombosis and Haemostasis.

[5]  D. Brotman,et al.  Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. , 2010, The American journal of medicine.

[6]  A. Spyropoulos.  To bridge or not to bridge: that is the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures , 2010, Journal of Thrombosis and Thrombolysis.

[7]  S. Iliceto,et al.  Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study , 2009, Circulation.

[8]  M. Samama,et al.  Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin , 2009, Thrombosis and Haemostasis.

[9]  C. Hammerstingl,et al.  Bridging of oral anticoagulation with low-molecular-weight heparin: Experience in 373 patients with renal insufficiency undergoing invasive procedures , 2009, Thrombosis and Haemostasis.

[10]  J. Douketis,et al.  Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). , 2008, The American journal of cardiology.

[11]  J. Douketis,et al.  The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[12]  E. Hylek,et al.  Risk of thromboembolism with short-term interruption of warfarin therapy. , 2008, Archives of internal medicine.

[13]  A. Turpie,et al.  Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT) , 2007, Journal of thrombosis and haemostasis : JTH.

[14]  J. Douketis,et al.  Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin , 2007, Journal of Thrombosis and Thrombolysis.

[15]  M. O’Donnell,et al.  Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin , 2007, Annals of Internal Medicine.

[16]  J. Douketis,et al.  Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry 1 , 2006, Journal of thrombosis and haemostasis : JTH.

[17]  M. Moia,et al.  Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets , 2006, Journal of thrombosis and haemostasis : JTH.

[18]  D. Hirschman,et al.  A study of the safety of continued anticoagulation for cataract surgery patients. , 2006, Nursing forum.

[19]  A. Spyropoulos.  Bridging of oral anticoagulation therapy for invasive procedures. , 2005, Current hematology reports.

[20]  D. Brotman,et al.  Low–Molecular-Weight-Heparins as Periprocedural Anticoagulation for Patients on Long-Term Warfarin Therapy: A Standardized Bridging Therapy Protocol , 2005, Journal of Thrombosis and Thrombolysis.

[21]  M. Pipitone,et al.  A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. , 2004, Journal of American Academy of Dermatology.

[22]  H. Schunkert,et al.  Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. , 2004, Chest.

[23]  J. Douketis,et al.  Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin , 2004, Circulation.

[24]  J. Douketis,et al.  Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. , 2004, Archives of internal medicine.

[25]  F. Frost,et al.  Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. , 2004, Chest.

[26]  James Douketis,et al.  Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.

[27]  F. Rosendaal,et al.  Oral anticoagulation in surgical procedures: risks and recommendations , 2003, British journal of haematology.

[28]  A. Turpie,et al.  Perioperative management of patients receiving oral anticoagulants: a systematic review. , 2003, Archives of internal medicine.

[29]  A. Girolami,et al.  Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[30]  H. Snooks,et al.  Can warfarin be continued during dental extraction? Results of a randomized controlled trial. , 2002, The British journal of oral & maxillofacial surgery.

[31]  S. Skates,et al.  Clinical Predictors of Prolonged Delay in Return of the International Normalized Ratio to within the Therapeutic Range after Excessive Anticoagulation with Warfarin , 2001, Annals of Internal Medicine.

[32]  P. Deyn,et al.  Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial , 2001, The Lancet.

[33]  C. Furberg,et al.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.

[34]  M Paloheimo,et al.  Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. , 2000, British journal of anaesthesia.

[35]  A. Zinsmeister,et al.  Postpolypectomy lower GI bleeding: descriptive analysis. , 2000, Gastrointestinal endoscopy.

[36]  C. Mullany,et al.  Modern management of prosthetic valve anticoagulation. , 1998, Mayo Clinic proceedings.

[37]  R. White,et al.  Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio , 1995, Annals of Internal Medicine.

[38]  R. Katholi,et al.  The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. , 1978, American heart journal.